Hepatic stellate cells (HSC) are a major target for antifibrotic therapies in the liver and in particular gene delivery to these cells would be relevant. Previously, we demonstrated that mannose 6-phosphate human serum albumin (M6P-HSA) coupled liposomes accumulate in HSC in fibrotic livers. Here we prepared a M6P-HSA modified viral vector that allows the targeted delivery of plasmid DNA to HSC. Therefore, UV inactivated hemagglutinating virus of Japan (HVJ) containing plasmid DNA was fused with M6P-HSA liposomes to yield HVJ liposomes targeted to HSC. These new particles had a diameter of approximately 200 nm, as determined by electron microscopy. In a carbon tetrachloride mouse model of liver fibrosis, M6P-HSA-HVJ-liposomes associated wit...
Background/Aims: Hepatic stellate cells (HSCs) play a key role in fibrogenesis. Here, we used mannos...
The hallmark of liver fibrosis is an increased extracellular matrix deposition, caused by an activat...
Myeloid immune cells promote inflammation and fibrosis in chronic liver diseases. Drug delivery syst...
Hepatic stellate cells (HSC) are a major target for antifibrotic therapies in the liver and in parti...
In fibrotic livers, collagen producing hepatic stellate cells (HSC) represent a major target for ant...
AbstractIn fibrotic livers, collagen producing hepatic stellate cells (HSC) represent a major target...
Liver fibrosis is a chronic disease that results from hepatitis B and C infections, alcohol abuse or...
Liver fibrosis is a chronic disease that results from hepatitis B and C infections, alcohol abuse or...
In order to deliver antisense oligonucleotides (asODN) into hepatocytes orientedly in the treatment ...
In the fibrotic liver, hepatic stellate cells ( HSC) produce large amounts of collagen and secrete v...
AIM: In this study, a hepatocyte-specific targeting technology was developed by modifying cationic l...
Background/Aims: In designing a versatile liposomal drug carrier to hepatic stellate cells (HSC), th...
Background/Aims: In designing a versatile liposomal drug carrier to hepatic stellate cells (HSC), th...
In this study, a hepatocyte-specific targeting technology was developed by modifying cationic liposo...
Background/Aims: Hepatic stellate cells (HSCs) play a key role in fibrogenesis. Here, we used mannos...
The hallmark of liver fibrosis is an increased extracellular matrix deposition, caused by an activat...
Myeloid immune cells promote inflammation and fibrosis in chronic liver diseases. Drug delivery syst...
Hepatic stellate cells (HSC) are a major target for antifibrotic therapies in the liver and in parti...
In fibrotic livers, collagen producing hepatic stellate cells (HSC) represent a major target for ant...
AbstractIn fibrotic livers, collagen producing hepatic stellate cells (HSC) represent a major target...
Liver fibrosis is a chronic disease that results from hepatitis B and C infections, alcohol abuse or...
Liver fibrosis is a chronic disease that results from hepatitis B and C infections, alcohol abuse or...
In order to deliver antisense oligonucleotides (asODN) into hepatocytes orientedly in the treatment ...
In the fibrotic liver, hepatic stellate cells ( HSC) produce large amounts of collagen and secrete v...
AIM: In this study, a hepatocyte-specific targeting technology was developed by modifying cationic l...
Background/Aims: In designing a versatile liposomal drug carrier to hepatic stellate cells (HSC), th...
Background/Aims: In designing a versatile liposomal drug carrier to hepatic stellate cells (HSC), th...
In this study, a hepatocyte-specific targeting technology was developed by modifying cationic liposo...
Background/Aims: Hepatic stellate cells (HSCs) play a key role in fibrogenesis. Here, we used mannos...
The hallmark of liver fibrosis is an increased extracellular matrix deposition, caused by an activat...
Myeloid immune cells promote inflammation and fibrosis in chronic liver diseases. Drug delivery syst...